Europe's Pharma Industry Faces Decline Amid US Policies and China's Biotech Growth

Europe's long-standing dominance in the pharmaceutical sector is reportedly ending, attributed to fragmented capital markets, single-market pricing, uneven reimbursement policies, and the impact of past US policies and China's burgeoning biotech industry.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

cnbcCatalan142d ago

Trump policies, China's biotech boom are ending Europe's pharma powerhouse era

Companies have long lamented Europe's fragmented capital markets, single-market adoption on pricing and clinical trials, and uneven reimbursement policies.

Read full article →

Europe's Pharma Industry Faces Decline Amid US Policies and China's Biotech Growth

Sources

Trump policies, China's biotech boom are ending Europe's pharma powerhouse era

Related Stories

Ebola Cases in DR Congo Surpass 6,000 as Outbreak Continues

England Pharmacies to Offer Free Quick Cholesterol Screening Tests

Housing Crisis Surpasses Addiction as Top Reason for Irish Charity Support Requests

Pakistan to Honor Nurse Who Rescued Sole Newborn From Hospital Fire